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The antero-posterior (AP) and dorso-ventral (DV) patterning of the neural tube is controlled in part by HOX and PAX transcription factors,
respectively. We have reported on a neural enhancer of Hoxd4 that directs expression in the CNS with the correct anterior border in the hindbrain.
Comparison to the orthologous enhancer of zebrafish revealed seven conserved footprints including an obligatory retinoic acid response element
(RARE), and adjacent sites D, E and F. Whereas enhancer function in the embryonic CNS is destroyed by separation of the RARE from sites D–
E–F by a half turn of DNA, it is rescued by one full turn, suggesting stereospecific constraints between DNA-bound retinoid receptors and the
factor(s) recognizing sites D–E–F. Alterations in the DV trajectory of the Hoxd4 anterior expression border following mutation of site D or E
implicated transcriptional regulators active across the DV axis. We show that PAX6 specifically binds sites D and E in vitro, and use chromatin
immunoprecipitation to demonstrate recruitment of PAX6 to the Hoxd4 neural enhancer in mouse embryos. Hoxd4 expression throughout the
CNS is reduced in Pax6 mutant SeyNeu animals on embryonic day 8. Additionally, stage-matched zebrafish embryos having decreased pax6a and/
or pax6b activity display malformed rhombomere boundaries and an anteriorized hoxd4a expression border. These results reveal an evolutionarily
conserved role for Pax6 in AP-restricted expression of vertebrate Hoxd4 orthologs.
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Hox genes encode homeodomain-containing transcription
factors that pattern the embryos of all animals (Featherstone,
2003). In taxa as diverged as flies and mammals, individual
Hox genes are expressed in precise and characteristic spatio-
temporal domains along the antero-posterior (AP) axis of the
trunk, assigning positional identity across this dimension, and
directing the subsequent morphogenesis of multiple tissues
and organs (Hombria and Lovegrove, 2003; Krumlauf,
1994). Numerous studies have confirmed the importance of
such restricted expression for normal development. The
identification and characterization of those proximal and
long-range enhancers controlling Hox expression have
therefore attracted considerable attention (Deschamps and
van Nes, 2005).
The 39 Hox genes of mice and humans are grouped at four
discrete chromosomal loci designated the HoxA through HoxD
clusters. The order of genes in each cluster is reflected in their
sequential activation in time and space along the AP axis of the
trunk, a process known as colinearity (Deschamps and van Nes,
2005). The four clusters are evolutionarily related and can be
aligned to reveal 13 paralog groups. Two genes of paralog
group 4, Hoxb4 and Hoxd4, are expressed in the embryonic
CNS with an anterior border at rhombomeres 6 and 7 (r6/7) in
the hindbrain (Morrison et al., 1997). Enhancers of both
neurectodermal and mesodermal expression are located 3′ of
Hoxb4 (Morrison et al., 1997). Within the 3′ neural enhancer,
early expression is dependent on an RARE (Gould et al., 1998)
that binds retinoid receptor heterodimers, whereas later
expression is directed by a pararegulatory element recognized
by HOXB4 and HOXD4 homeoproteins and capable of setting
the correct r6/7 border (Gould et al., 1997). As for Hox genes in
Drosophila, the maintenance of Hoxb4 in a repressed state is
controlled by chromatin modifying products of the Polycomb
family (Suzuki et al., 2002).
These and other studies (Deschamps and van Nes, 2005;
Gavalas and Krumlauf, 2000; Krumlauf, 1994) have estab-
lished some of the major players at the DNA and protein levels
acting through Hox neural enhancers. Nonetheless, the
identified factors alone cannot account for all aspects of
neural-specific Hox gene expression, and virtually nothing is
known about how multiple transcriptional regulators act
combinatorially to implement the precise spatio-temporal
activation of diverse Hox enhancers. We have used mutational
analysis in transgenic mouse embryos, coupled with phyloge-
netic footprinting with zebrafish hoxd4a, to identify cis-acting
elements within the murine Hoxd4 neural enhancer (Morrison
et al., 1997; Nolte et al., 2003; Zhang et al., 1997, 2000). In
addition to an RARE conserved in murine Hoxb4 and zebrafish
hoxd4a, we have noted six closely clustered footprints
suggestive of functionally important transcription factor
binding sites (Nolte et al., 2003). Once functions for such
conserved elements are confirmed, a major challenge is to
determine the specific transcription factors that recognize them,
and how they cooperate with each other to set the correct
Hoxd4 expression domain.Region-specific neural differentiation along the dorso-
ventral (DV) axis of the neural tube is accomplished through
the spatially restricted expression of three homeodomain-
containing proteins: PAX3, PAX6, and NKX2.2 (Wilson and
Maden, 2005). While Pax3 is expressed most dorsally, Pax6
transcripts occupy a broad medial domain in mid-gestational
mouse embryos. Besides the DNA-binding homeodomain
(HD), PAX3 and PAX6 harbor a so-called paired domain
(PD), itself composed of two distinct DNA-binding structures
(Chi and Epstein, 2002; Simpson and Price, 2002; Underhill,
2000). Pax6 and its orthologs are master regulators of eye
development throughout the animal kingdom, and Pax6
mutation in humans and mice leads to ocular dysgenesis
(Callaerts et al., 1997). In addition, Pax6 mutant mice display
malformations of the olfactory epithelium, pancreas, forebrain,
hindbrain, and spinal cord, including altered motor neuron and
interneuron identity in the latter two tissues (Ericson et al.,
1997; Osumi et al., 1997).
Here, we further characterize the murine Hoxd4 neural
enhancer and show that three conserved elements directly
adjacent to the RARE contribute to enhancer function in a
stereospecific manner. PAX6 binds two of these elements in
vitro, and is recruited to the enhancer in mouse embryonic trunk
where Hoxd4 is active, but not in cells of the head that do not
express Hoxd4. Loss of Pax6 decreases Hoxd4 expression in
the early mouse neural tube, consistent with broader AP and DV
activation of Pax6 at early developmental times. Confirming the
evolutionary conservation of PAX6 function in Hoxd4 neural
expression, reduced pax6 activity in somite-matched zebrafish
embryos alters rhombomeric boundaries and anteriorizes the
hoxd4a expression border. Our results reveal a role for Pax6 in
AP-restricted Hox gene expression, and suggest that stereospe-
cific interactions between PAX6 and adjacently bound retinoid
receptors may be important forHoxd4 neural enhancer function.
Materials and methods
Transgene constructs
Mutations of the mouse neural enhancer were generated by PCR overlap
extension (Ho et al., 1989). The PCR primers used to generate construct 3 were
(sense) 5′-TTTCTGTTCGCCCCGCTGTA-3′, (antisense) 5′-TACAGCGGGG-
CGAACAGAAA-3′; construct 4 (sense) 5′-TGTACCGCGGCCTGGAGGAC-
TGACCTC-3′, (antisense) 5′-CAGGCCGCGGTACAGCTAATCGAACAG-3′;
construct 5 (sense) 5′-CAGAATCACCCCCGGTTCACCCAGAGGACA-3′,
(antisense)5′-TGTCCTCTGGGTGAACCGGGGGTGATTCTG-3′; construct 6
(sense) 5′-AGGACACCCCCAATTTTCTGTTCG-3′, (antisense) 5′-CGAACA-
GAAAATTGGGGGTGTCCT-3′; construct 7 (sense) 5′-AGGACACCCCCAA-
AGGGAATTTTCTGTTCG-3′, (antisense) 5′-CGAACAGAAAATTCCCTTTG-
GGGGTGTCCT-3′; construct 8 (sense) 5′-TTTCGTTCCCCCCGATTAG-3′,
(antisense) 5′-CTAATCGGGGGGAACAGAAA-3′; construct 9 (sense) 5′-
GTTCGATTACCCCCGCTGTA-3′, (antisense) 5′-TACAGCGGGGGTAATC-
GAAC-3′. These constructs were cloned into pSHlacZpA (Zhang et al., 2000). All
clones were confirmed by manual sequencing.
Production of transgenic mice
The preparation and microinjection of the transgenes have been previously
described (Nolte et al., 2003). Fertilized donor eggs were obtained from
CBA×C57Bl6/J F1 mice bred in house. Microinjected embryos were implanted
into CD1 (Harlan) pseudopregnant fosters.
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whole-mount in situ hybridization, and cryostat sectioning
Embryo collection, staining, and genotyping have been previously described
(Nolte et al., 2003). Genotyping of SeyNeu embryos was performed as described
(Hill et al., 1991; Xu et al., 1997) on extraembryonic membranes or on the
embryos themselves following staining and photography. For whole-mount in
situ hybridization, embryos were dissected and processed with digoxigenin-
UTP-labeled RNA probes as described earlier (Henrique et al., 1995). Hoxd4
expression was detected with the probe BgH (Folberg et al., 1997) which is
complementary to the 3′ end of Hoxd4 region, and detects all Hoxd4 transcripts.
Embryos presented in any given panel of Fig. 6 were collected at the same time
and stained in the same experiment. In the case of Fig. 6C, the embryos were also
stained in the same well followed by genotyping on the whole embryos. For the
cryosectioning, embryos were embedded in OCT and 20 μm sections were
collected on a Leica cryostat.
Production and analysis of zebrafish embryos having reduced pax6
function
Morpholino antisense oligonucleotides (MO)were obtained fromGene Tools
(Philomath, OR), and were injected as described (Draper et al., 2001). In situ
hybridization was performed as described (Jowett and Yan, 1996). The sequence
of the MOs was as follows: pax6a, 5′-TTTGTATCCTCGCYGAAGTTCTTCG-
3′ and pax6b, 5′-CTGAGCCCTTCCGAGCAAAACAGTG-3′. Probes used for
detection of eng2b, krox20a, and hoxd4a have been previously described (Ekker
et al., 1992; Oxtoby and Jowett, 1993; Prince et al., 1998). The pax6a probe was
a gift from the Westerfield laboratory (Püschel et al., 1992), and the pax6b probe
was obtained from ZIRC (cb566).
ChIP and real-time PCR
Chromatin immunoprecipitation (ChIP) experiments were performed as
described previously (Rastegar et al., 2004). For ChIP with P19 cells, we used
106 cells per immunoprecipitation. Briefly, the cells were cross-linked with 1%
formaldehyde, collected, and washed twice with ice-cold PBS containing protease
inhibitor cocktail from Roche (complete EDTA-free). The cells were resuspended
in 200 μl of sodium dodecyl sulfate (SDS) lysis buffer on ice for 10 min and then
sonicated with 10 sets of 10-s pulses by a Betatec Sonics Vibra Cell sonicator to an
average DNA size of 600 bp. ChIP experiments with embryonic tissues were done
as described (Rastegar et al., 2004). E8.0 and E10.5 embryos were cross-linked
with 1% formaldehyde diluted in serum-freeDulbecco'smodified Eagle'smedium
(DMEM) for 15 min at room temperature. The cross-linked embryos were washed
three times with PBS containing protease inhibitors for 10 min at room
temperature. The E8.0 embryos were dissected into anterior (head) and posterior
(trunk) regions, as described before (Rastegar et al., 2004). The E10.5 embryos
were mildly digested with 0.5% trypsin in Ca2+-free DMEM containing 20 mM
HEPES for 25 min at 4°C in order to finely dissect the neural tube from the
developing somites and other embryonic tissues. After a wash step with Ca2+-
containing DMEM, fine forceps were used to separate the neural tube from the
neighboring tissue under a dissecting microscope. A section was then made with a
razor blade at the base of the otic vesicle, parallel to the r6/7 boundary, separating
spinal cord tissue from the head. The cells (106)were lysed for 15min on ice in 1ml
of cell lysis buffer [5 mM piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES; pH
8.0), 85 mMKCl, 0.5% NP-40], pelleted, and incubated with 200 μl of SDS lysis
buffer for an additional 20 min on ice to release the chromatin. Chromatin samples
were then sonicated and processed further as for P19 cells. The chromatin was
precleared with salmon spermDNA–proteinA–agarose beads for 1 h, followed by
an overnight incubation with different antibodies. For each experiment with P19
cells, we used 5 μl of anti-PAX6-C-terminal antibody (Turque et al., 1994) per half
million cells. Chromatin–antibody complexes were collected by reincubation for
1 h with protein A–agarose beads. Washes were performed according to the
Upstate protocol. Chromatin was eluted from the beads and cross-links were
reversed at 65°C for 4 h. DNA was phenol–chloroform extracted and ethanol
precipitated. Five percent (by volume) of the immunoprecipitated material was
used as a template for real-time PCR by use of a SYBR Green Taq ReadyMix kit
for quantitative PCR fromSigma and aRoche LightCycler. PCR productswere run
in 1.5% agarose gels and visualized by ethidium bromide staining. Quantificationof the LightCycler datameasured the relative amounts of initial target sequence and
expressed them as a percentage of the input. Standard curves of serially diluted
target sequences were used for quantification.
Primers
The sequence of primers used for ChIP of the Hoxd4 enhancer and gapdh
control has already been published (Rastegar et al., 2004). The primers used for
the bandshift experiments were as follows:
RARE-D–E:
5′-ATCAGGTTCACCCAGAGGACAAATTTTCTGTTCGAT-
TAGCTGT-3′
5′-ACAGCTAATCGAACAGAAAATTTGTCCTCTGGGTGAAC-
CTGAT-3′
D-E:
5′-ACAAATTTTCTGTTCGATTAGCTGTATTT-3′
5′-AAATACAGCTAATCGAACAGAAAATTTGT-3′
D:
5′-GAGGACAAATTTTCTGTTCGAT-3′
5′-ATCGAACAGAAAATTTGTCCTC-3′
E:
5′-GAGGACAACCCGCGGATTCGATTAGCTGTATTT-3′
5′-AAATACAGCTAATCGAATCCGCGGGTTGTCCTC-3′
P3: paired homeodomain binding site (Wilson et al., 1995):
5′-GGGAATAATCTGATTACAGGG-3′
5′-CCCTGTAATCAGATTATTCCC-3′
PAX6CON: PAX6 PD consensus binding site (Epstein et al., 1994)
5′-GCAAATTTTCACGCTTGAGTTCACAGCT-3′
5′-AGCTGTGAACTCAAGCGTGAAAATTTGC-3′
5C′s between RARE and site D:
5′-ATCAGGTTCACCCAGAGGACACCCCCAATTTTCTGTTCGA-
TTAGCTGT-3′
5′-ACAGCTAATCGAACAGAAAATTGGGGGTGTCCTCTGGGTG-
AACCTGAT-3′
5C′s between site D and E:
5′-ATCAGGTTCACCCAGAGGACAAATTTTCTGTTCCCCCCG-
ATTAGCTGT-3′
5′-ACAGCTAATCGGGGGGAACAGAAAATTTGTCCTCTGGG-
TGAACCTGAT-3′
Total cell extracts and immunoblotting
Total P19 cell extracts or embryonic cell extracts were prepared as described
previously (Rastegar et al., 2004). Twenty-microgram samples of total cell
extracts were run in SDS-10% polyacrylamide gels and transferred to
nitrocellulose membranes. The membranes were blocked for 1 h at room
temperature in 5% nonfat milk powder and 0.1% Tween 20 in PBS (PBS-T).
Incubation with the primary antibody was performed either for 2 h at room
temperature or overnight at 4°C, and the membranes were subsequently washed
in 0.1% PBS-T. Incubation with a horseradish peroxidase-conjugated secondary
antibody was done for 45 min at room temperature, followed by washing with
0.1% PBS-T. Bound immunoglobulins were visualized with an enhanced
chemiluminescence detection system (Mandel Biotech). The membranes were
then stripped and reprobed with an anti-actin antibody as a loading control.
Antibodies
The anti-PAX6 C-terminal antibody and the anti-PAX6 paired domain
antibody (Turque et al., 1994) are kind gifts of Dr. Simon Saule. The anti-actin
AC40 antibody was purchased from Sigma.
Immunohistochemistry
The protocol for immunohistochemistry on sectioned embryos (Haller et al.,
2002; Hogan et al., 1994), and for embryo fixation and sectioning (Daniels et al.,
1996) were as described.
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assay
PAX6 protein was generated with an Sp6 TNTcoupled in vitro transcription-
translation kit (Promega). Reactions containing [35S] methionine were
performed in parallel to verify translational efficiency. Electrophoretic mobility
shift assay (EMSA) was performed as described previously (Phelan et al., 1995).Fig. 1. (A) Diagram of the Hoxd4 transcription unit contained in the pSNlacZpA
transgene showing downstream (P1) and upstream (P2) promoters, non-coding
(white boxes) and coding exons (black boxes), homeobox (dark grey box), the 3′
region containing neural and mesodermal enhancers (light grey, region A), the
minimal neural enhancer, the position of the RARE (black circle) and a sequence
comparison of the most highly conserved neural enhancer elements shared by
mouse, human, chicken and zebrafish (RARE plus sites A through D). The half
sites in the RARE are given by overlying half-arrows. Dashes are placed
opposite base pair insertions. (B) Mutations introduced in the region spanning
the RARE and sites D, E and F. Construct number is given at the left. Base
substitutions are given directly below the corresponding wild-type sequence.
Sites of 5- or 11-bp insertions are given along with the 6-bp spanning the
insertion site.Results
The sequence and spacing of conserved elements direct Hoxd4
neural enhancer activity
We have shown that the zebrafish hoxd4a gene bears an
orthologous neural enhancer conserved in position, sequence
and function with its murine ortholog (Zhang et al., 2000).
Phylogenetic footprints A through F obtained by sequence
comparison of the zebrafish and mouse enhancers are likewise
conserved in human and chicken (Fig. 1A). Our previous work
showed that a 3′ deletion of the murine Hoxd4 neural enhancer
removing sites D, E and F (Fig. 1A) abolishes CNS expression in
transgenic mouse embryos (Zhang et al., 2000). To understand
the contribution of each individual site to enhancer function, we
used site-directed mutagenesis in the same reporter context and
tested the mutants in transient transgenic analysis (Fig. 1B). As
reported previously (Zhang et al., 2000), mutation of site D
results in a posteriorization of the anterior border (construct 2,
Figs. 2, 3C). We examined this mutant in greater detail by
making flatmounts of the hindbrain region which more clearly
reveal the extent of posteriorization (Fig. 3G). The anterior
expression border of site D mutants is ragged and retracted, with
greater posteriorization in the ventral aspect. Mutation of site E
gave a similar result, although the discrepancy between ventral
and dorsal aspects was more pronounced (construct 3, Figs. 2,
3D, H). Mutating site F produced more subtle effects, with a
slight posteriorization evident on the left side of the embryo
shown, in addition to variable cell-to-cell expression in the
dorsal aspect (construct 4, Figs. 2, 3E, I).
The above results show that neural enhancer activity is
posteriorized by individual mutation of sites D, E, and F.
However, simultaneous deletion of all three sites abolishes
enhancer function (Zhang et al., 2000). This suggests that these
sites make synergistic contributions to the overall strength of
neural expression. We noted that the spacing between the RARE
and site D (3 bp), and between sites D and E (2 bp) is
evolutionarily conserved (Fig. 1B), suggesting that factors
bounds to these elements may physically interact in a spatially
constrained manner. To test for such stereospecific interactions,
we introduced 5-bp insertions between the various sites in the
Hoxd4 neural enhancer, thereby displacing factors bound on
either side of the insertion by 180° around the DNAdouble helix.
When placed between site C and the RARE, a 5-bp insertion had
no effect on transgene expression (construct 5, Figs. 2, 3J, O).
However, when the insertion was located between the RARE
and site D, lacZ expression in the neural tube was largely
eliminated (construct 6, Figs. 2, 3K, P). Thus, separating sites D,
E and F from the RARE by 5 bp is as deleterious as removal ofthese sites entirely, andmore crippling thanmutation of D, E or F
individually.
To assess the spacing requirements of individual elements,
we introduced 5 bp between sites D and E (construct 8, Figs. 2,
3M, R), or E and F (construct 9, Figs. 2, 3N, S). The insertion
between sites D and E resulted in a posteriorization, but not
elimination, of transgene expression, similar to mutation of site
D. Although the distance between sites E and F is not conserved
between mice and fish, the introduction of five cytosines
anteriorized transgene expression toward the r5/6 border. In all
embryos expressing this construct, ectopic expression in the
head was also greatly enhanced. Thus, only insertion between
the RARE and site D mimicked deletion of all three sites D, E
and F by abolishing enhancer activity.
If a 180° displacement of the RARE from sites D–E–F
disrupts stereospecific interactions between adjacently bound
factors, then realignment by insertion of six additional
nucleotides (one full turn) should rescue neural expression.
Such a construct bearing an 11-bp insertion between the
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the Hoxd4 neural expression domain (construct 7, Figs. 2, 3L,
Q), though not in anterior-most cells adjacent to the r6/7
border. We conclude that stereospecific interactions between
retinoid receptors and factor(s) bound to at least site D are
critical for Hoxd4 neural enhancer function.
PAX6 is recruited to the Hoxd4 neural enhancer in vitro and in
vivo
Mutations involving sites D or E (constructs 2, 3 and 8)
differentially affected transgene expression along the neural D–
Vaxis, suggesting the involvement of transcriptional regulators
directing D–V patterning. PAX3 and PAX6 are two such factors
(Wilson and Maden, 2005). Moreover, Pax6 is expressed in the
hindbrain and throughout the neural tube as early as E8.0
(Walther and Gruss, 1991), a few hours before the onset of
Hoxd4 expression (Featherstone et al., 1988; Gaunt et al.,
1989). Inspection of the sequence spanning sites D and E
revealed moderate identity with PAX6CON (Epstein et al.,
1994), the consensus binding site for the PAX6 PD (Fig. 4A).
Given that many naturally occurring PAX6 binding sites are
poorly related to the consensus (Fig. 4A) (Cvekl et al., 1994,
1995), we produced PAX6 in rabbit reticulocyte lysates and
tested by EMSA for specific binding to a double-stranded
oligonucleotide probe spanning the RARE and sites D and E.
Unprogrammed lysate gave several bands, some of which were
due to endogenous rabbit PAX6 (Supplemental Fig. 1).
Programmed lysate expressing murine PAX6 gave an additional
DNA-bound complex that was specifically competed byFig. 2. Constructs used in transgenic analysis of the Hoxd4 neural enhancer.
Mutation of sites D, E, and F are indicated by a cross through the corresponding
site. Half- and full-helical insertions are shown with inverted triangles above the
point of insertion. #Express/total Tg: the fraction of embryos expressing the
construct over the total number of transgenics as determined by PCR on yolk sac
material. r6/7 border: the number of embryos displaying the correct r6/7 anterior
expression border over the total number of transgenics. Numbers for construct 1
are taken from (Zhang et al., 2000).PAX6CON (Epstein et al., 1994), but not by the PAX HD
binding site P3 (Wilson et al., 1995) (Fig. 4B) or non-specific
oligonucleotides (data not shown). These implicate the PAX6
PD in binding to the Hoxd4 neural enhancer, and suggest that
the HD plays at most an indirect role.
Confirmation that the shifted band was indeed due to
PAX6 binding was obtained with specific antibodies. Two
polyclonal antibodies directed against the PAX6 HD or C-
terminus (Turque et al., 1994) supershifted the presumptive
PAX6 complex (Fig. 4C), whereas a control polyclonal
antibody against murine HOXD4 did not (data not shown).
Likewise, complexes formed on the same site with lysates of
neurally differentiating P19 cells or extracts of E10.5
embryonic spinal cord were super-shifted by PAX6 antibody
(data not shown).
To refine the region bound by PAX6, cold competitors
corresponding to sites D–E, D only, and E only, were used with
the RARE-D–E probe. While the D–E probe efficiently
competed PAX6 binding, neither of sites D or E alone were
effective competitors (Fig. 4D). We used competitor oligonu-
cleotides to test PAX6 binding to two 5-bp spacing mutants
used in transgenic analysis. Five-bp insertions between the
RARE and site D, or between sites D and E, were both effective
competitors in EMSA (Fig. 4D), suggesting that altered
expression seen with each mutant is not due to decreased
intrinsic affinity for PAX6 alone. Last, we confirmed that a
labeled probe containing sites D and E but not the RARE was
directly bound by PAX6 (Fig. 4E). These results implicate both
sites D and E in the binding of the PAX6 PD, consistent with
the homology of D–E with the PAX6 PD consensus binding
site, and the placement of D and E at positions predicted to
contact the PD N- and C-subdomains, respectively (Fig. 4A)
(Xu et al., 1999). They also reveal a possible tolerance by the
PAX6 PD for recognition of separated sites for N- and C-
subdomain binding.
The ChIP assay was used to study PAX6 binding to the
Hoxd4 neural enhancer in vivo. The Hoxd4 gene is inactive in
undifferentiated P19 EC cells, but is induced within 2 days
following neural induction by RA. Induction is accompanied by
chromatin modification and transcription factor recruitment to
the enhancer (Rastegar et al., 2004). ChIP assays performed on
chromatin from P19 cells revealed recruitment of PAX6 to the
Hoxd4 neural enhancer specifically during neural induction
(Fig. 5A). Although PAX6 is present in P19 before neural
differentiation, it is not found at the enhancer, consistent with
specific recruitment during the activation of Hoxd4.
We have previously shown that chromatin modification and
transcription factor recruitment at the Hoxd4 enhancer have
already commenced on early day 8 specifically in the trunk
neural tube whereHoxd4will be expressed a few hours later. By
contrast, these changes do not take place in the head region
where Hoxd4 remains inactive (Rastegar et al., 2004). ChIP
assays on chromatin from dissected regions of E8.0 embryos
reveal PAX6 recruitment to the Hoxd4 neural enhancer only in
the trunk and not the head, thus anticipating gene activation in
the trunk at E8.25 (Figs. 5A, B). By E10.5, however, PAX6 is
no longer associated with the enhancer, though Hoxd4 remains
Fig. 3. Binding site or insertional mutations alter the setting of the anterior neural expression border of Hoxd4 transgenes. (A) Cartoon of E9.5 embryo with the CNS
outlined in continuous red lines and the boundaries between rhombomeres denoted by dashed red lines. The Hoxd4 expression domain with the r6/7 expression
boundary is given by solid red fill. The posterior border of the otic vesicle (arrow head) lies just anterior to the r6/7 border. (B–S) Lateral and flatmount views of
transgenic embryos. Construct numbers and pictorials are given on top of each pair of photographs. The posterior edge of the otic vesicle (right side) is given by a solid
white line.
587C. Nolte et al. / Developmental Biology 299 (2006) 582–593actively transcribed (Fig. 5B). Together, these results demon-
strate specific association of PAX6 with the Hoxd4 neural
enhancer.
Hoxd4 neural enhancer activity is dependent on PAX6
Pax6 expression is excluded from the most dorsal and
ventral regions of the neural tube in mid-gestational mouse
embryos (Wilson and Maden, 2005), raising questions as to
how it could influence Hoxd4 expression across the entire D–
V axis. We assessed to what extent Hoxd4 and Pax6 are co-expressed in the early neural tube by examining the
distribution of Hoxd4 transcripts and PAX6 protein along the
DV axis of the posterior rhombencephalon at E8.5. Immuno-
histochemistry with a polyclonal PAX6 antibody (Turque et
al., 1994) revealed broad distribution across the D–V axis of
the posterior hindbrain (Fig. 6B) that is largely coextensive
with Hoxd4 transcripts (Fig. 6A). Thus, early PAX6 expression
shows less DV restriction than at later stages, consistent with
observations in chick (Ericson et al., 1997), and providing for
a direct role in regulating Hoxd4 throughout this axis in the
neural tube.
Fig. 4. PAX6 binds sites D and E via the paired domain. (A) Comparison of the consensus PAX6 PD binding site PAX6CON (P6CON) with the sequence ofHoxd4D–
E (below) and the PAX6 binding site of the αA-crystallin gene (cryst) (Cvekl et al., 1995). Base pair identity shown by dots. Sites D and E are underlined, and the
regions predicted to contact the N- and C-subdomains of the PD are bracketed (Xu et al., 1999). (B–E) EMSA analysis of PAX6 binding to the Hoxd4 neural enhancer.
Position of specific PAX6-DNA complexes, of supershifted complexes (SS), and probe and probe identity, are given at the left of each panel. The protein used in each
reaction is given at the top of each lane. Competitors and antibodies are indicated above horizontal lines top-most in each panel. Probe, free probe. The prominent
shifted complex in the “mock” lane is due to the presence of endogenous PAX6 in rabbit reticulocyte lysates as shown by controls in EMSA and Western blot analysis
(Supplemental Fig. 1). Mock, unprogrammed reticulocyte lysate. PAX6, in vitro translated murine PAX6. αPD, antibody against PAX6 PD. αCT, antibody against
PAX6 C-terminus. P3, competitor harboring the consensus PAX HD binding site. P6CON, competitor harboring the consensus PAX6 PD binding site PAX6CON. (B)
PAX6 binds to an oligonucleotide spanning the RARE and sites D and E of the Hoxd4 neural enhancer. Binding is dependent on the PD but not the HD, as evidenced
by competition with the PD binding site PAX6CON (P6CON) but not the HD binding site P3. The panel has been digitally spliced between the third and fourth lanes.
(C) The presumptive PAX6 complex is supershifted by antibodies against the PAX6 PD and C-terminus. (D) PAX6 binding is dependent on both sites D and E, and is
not disrupted by a 5-bp insertion between D and E. (E) A binding site containing only sites D and E is sufficient to recruit PAX6.
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in the vertebrate embryo, we assessed gene activity in two
developmental contexts: first, inmouse embryos homozygous for a
Pax6 null mutation, and second, in zebrafish embryos having
reduced pax6 co-ortholog function following transcript knock-
down with morpholino oligonucleotides. Hoxd4 transcript distri-
bution was examined in the SeyNeu mouse strain. The SeyNeu strain
of Pax6mutants arose from a chemically treated stock, and bears a
point mutation in a splice donor site that effectively truncates the
resulting protein after the HD, thereby deleting the C-terminal
transactivation domain (Hill et al., 1991). SeyNeu heterozygotes
present olfactory and ocular malformations typical of Pax6
mutants, while homozygotes die at birth (Callaerts et al., 1997).
Hoxd4 expression in stage-matched embryos from matings of
SeyNeu heterozygotes was assessed by whole-mount in situ
hybridization. Wild-type and SeyNeu heterozygotes displayednear-equivalent levels of Hoxd4 expression in the neuroectoderm.
Of the four homozygous SeyNeu embryos obtained, two could be
matched by somite number to wild-type and heterozygous
littermates (Fig. 6). SeyNeu homozygotes revealed markedly
decreased expression throughout the neural tube at E8.5 (10 to
11 somites, Fig. 6C) and E8.75 (13 to 14 somites, Figs. 6E–F). The
remaining two homozygotes likewise showed decreased Hoxd4
expression, but were developmentally delayed by one somite (data
not shown). By E11.0, wild-type Hoxd4 expression levels are
restored in the CNS of SeyNeu homozygotes (data not shown),
suggesting independent regulatory mechanisms at later develop-
mental stages.
The zebrafish genome has but a single Hoxd4 ortholog,
hoxd4a. The combined expression patterns of the two
zebrafish Pax6, pax6a and pax6b, comprise the entire
hindbrain field (Supplemental Fig. 2) and therefore fully
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address the role of pax6a and pax6b in hoxd4a expression,
one-cell stage embryos were injected with morpholino
antisense oligonucleotides (MOs) for pax6a and/or pax6b,
and messages for eng2b, krox20a, and hoxd4a were detected
by whole-mount in situ hybridization. Decreased expression
of the PAX6 target gene eng2b at the midbrain–hindbrain
border confirmed that the MOs had indeed engendered pax6a
and pax6b loss-of-function (Fig. 7). By comparison to
control-injected, somite-matched embryos (14 and 16
somites), the expression patterns for krox20a and hoxd4a
revealed developmental perturbations to hindbrain patterning.
Dorsal views of both 14-somite (Figs. 7A–D) and 16-somite
embryos (Supplemental Fig. 3) show a decrease in the gap
separating the krox20a expression domain in r5 from the
anterior domain of hoxd4a expression in r7. Lateral views of
14-somite embryos provided more detailed information (Figs.
7E–H). Strikingly, the AP widths of r5 and r6 were contracted
ventrally relative to control-injected embryos, and were
accompanied by anteriorization of the hoxd4a expressionFig. 5. PAX6 is recruited to the Hoxd4 neural enhancer in vivo. (A) Results of
ChIP and Western blot (WB) analyses, as indicated below the panels. One set of
assays was performed on P19 cells at the beginning (day 0, D0) and 2 days
following (D2) the onset of neural differentiation (top panels).Hoxd4 expression
is turned on at D2. Remaining assays used tissue extracts of E8.0 anterior (A)
and trunk (P), and E10.5 head (H) and spinal cord (SC). d4 enh, amplification of
the Hoxd4 neural enhancer. gapdh, amplification of a genomic region of a
gapdh control. PCR was performed on unprecipitated chromatin (input),
mock precipitated without antibody (no Ab), and anti-PAX6 antibody. Western
blots were probed with antibodies against PAX6 or actin, as indicated.
Molecular mass (kDa) for both species is given at right. Western blots show that
differences in PAX6 recruitment are not due to global changes in PAX6 levels in
the cell. (B) ChIP results from the LightCycler were quantitated and expressed
as percent input. Error bars show the SEM from at least two independent
experiments.border in its more ventral aspects. This phenotype was most
prominent in embryos injected with both pax6a and pax6b
MOs (Fig. 7H). In fact, AP patterning defects were detected in
virtually all rhombomeres 1 through 7. These phenotypes were
seen in 98 of 110 (pax6aMO), 83 of 85 (pax6bMO), and 95 of
102 (pax6a+pax6bMOs) injected embryos. Combined with the
overall lower expression levels of hoxd4a in the experimentally
injected embryos, these results confirm a role for Pax6 in setting
both the anterior border and strength of Hoxd4 expression in
vertebrate embryos.
Discussion
Sequence and spacing requirements at the Hoxd4 neural
enhancer
Phylogenetic footprinting (Tagle et al., 1988) assumes a
strong evolutionary selection against base substitution within
transcription factor binding sites but not in surrounding
sequences. Sequence conservation has been used successfully
in the past to identify cis-acting regulatory elements in Hox
enhancers (Gould et al., 1997), and our own previous work
revealed seven such footprints in a conserved core within the
neural enhancers of mouse and zebrafish Hoxd4 orthologs
(Nolte et al., 2003). Our present and previous studies show that
all four footprints examined to date (RARE, D, E and F) do
indeed contribute to Hoxd4 enhancer function.
Our results further show that the insights of this method are
acquired not only through sequence conservation, but also
through evolutionary conservation of spacing between foot-
prints. We used the standard tests for stereospecific interactions
on DNA by insertion of 5 or 11 bp, corresponding to one half
turn and one full turn of the helix, respectively (Takahashi et al.,
1986). Five-bp insertions between RARE-D, D–E and E–F all
displaced transgene expression from the correct r6/7 boundary
in the hindbrain. This was most dramatic for a 5-bp insertion
between the RARE and site D, resulting in almost complete loss
of enhancer function. That this was due to a spacing effect, and
not to the disruption of a cryptic transcription factor binding site
or the allosteric effects of flanking residues on retinoid receptor
binding (Oosterveen et al., 2003), was proved by the striking
restoration of expression following extension of the insertion to
11 bp. The simplest interpretation of the combined results is that
correct Hoxd4 expression is dependent on stereospecific
interactions between retinoid receptors and one or more
transcription factors bound to sites D, E and F.
PAX6 and Hoxd4 enhancer function
We present multiple lines of evidence implicating PAX6 in
the control of Hoxd4 neural enhancer activity. PAX6 binds a
sequence spanning sites D and E that shows some similarity to
the established consensus. Significant divergence from the
consensus is typical of PAX binding sites (Callaerts et al., 1997).
Likewise the adjacent RARE in the Hoxd4 neural enhancer
differs from the DR5 consensus at one position, resulting in a 3-
fold reduction in affinity for an RXRα•RARα heterodimer
Fig. 6. Hoxd4 expression is reduced in the neural tube of Pax6 mutant embryos. (A) A wt E8.5 embryo probed for Hoxd4 expression by whole-mount in situ
hybridization was embedded and sectioned by cryostat. The section shown is at the level of the posterior hindbrain. (B) The same section was probed for PAX6 protein
distribution across the DVaxis using a 1:100 dilution of an anti-PAX6 C-terminal antibody (green). Nuclei in the same section were stained with DAPI (blue) and the
two images superimposed. (C–F) Somite-matched littermates from crosses of SeyNeu heterozygotes were examined in parallel for Hoxd4 expression by whole-mount
in situ hybridization. (C) Hoxd4 expression is decreased in E8.5 SeyNeu homozygotes (Sey/Sey) vs. wt (+/+). Embryos are at the 10- to 11-somite stage. (D)
Comparable Hoxd4 transcript levels in E8.0 SeyNeu heterozygotes vs. wt. Embryos are at the 7-somite stage. (E, F) Lateral (E) and dorsal (F) views of Hoxd4
expression in wt, heterozygous and homozygous SeyNeu embryos at E8.75. Embryos are at the 12- to 13-somite stage.
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binding sites in natural regulatory regions are the norm, and may
ensure that stable complexes of enhancer binding proteins are
only formed when the full complement of factors are present to
supply compensatory stabilizing protein-protein contacts. Such
interactions should be stereospecific in many instances and
would account for the spacing requirements noted here.
The PAX6CON, but not the P3 oligonucleotide, competed
PAX6 binding in EMSA, implicating the PAX6 PD, but not the
HD, in binding to region D–E. By comparison to the crystal
structure of the PAX6 PD bound to an extended consensus (Xu
et al., 1999), the N-terminal DNA binding domain of the PD (N
subdomain) should contact site D of the Hoxd4 neural enhancer,
whereas the C-terminal DNA binding domain (C subdomain)
should contact site E (Fig. 4A). The five-bp insertion between
sites D and E would not alter nucleotides normally recognized
by either N or C subdomain, but rather the region contacted by
the extended polypeptide linker that joins these two DNA-binding structures (Xu et al., 1999). Mutation of site E and the
5-bp insertion between D and E evoke very similar alterations in
transgene expression, both in terms of the extent of poster-
iorization and the altered DV profile of the retracted border.
This would be most easily explained by a common disruption of
DNA binding by the C subdomain of the protein, in one case
due to the loss of site E, and in the other by preventing binding
by both PD subdomains at once. The latter explanation also
assumes that the physical constraints of the altered enhancer
favor binding by the N subdomain to site D over that of the C
subdomain to site E.
By contrast to other 5-bp insertions, that between sites E and
F anteriorized transgene expression into r6, and greatly
augmented ectopic expression in the area of the forebrain,
eye, and olfactory epithelium, all tissues known to come under
Pax6 control (Callaerts et al., 1997). This result suggests a
relaxation of negative regulatory controls, perhaps exercised
through inhibitory factor(s) bound to site F and whose
Fig. 7. Reduced pax6 function results in widespread AP patterning defects in the zebrafish hindbrain, and decreased and anteriorized hoxd4a expression. MOs against
pax6a and pax6b were used to assess the effect of reduced Pax6 function on hoxd4a expression in the hindbrain of 14-somite embryos. Panels show dorsal (A–D) and
lateral views (E–H) of embryos injected with one or both MOs and simultaneously probed for the expression of three genes, eng2b, krox20a, and hoxd4a. mhb, mid-
hindbrain region. ctrl MO, control morpholino-substituted oligonucleotide.
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the same mutation may reinforce interactions with adjacently
bound PAX6.
While our findings demonstrate that PAX6 directly binds and
regulates the Hoxd4 neural enhancer, they provide no definitive
proof that it is this factor which undergoes stereospecific
interactions with the adjacently bound retinoid receptors.
Nonetheless, adjacent binding sites for retinoid receptors and
PAX6 have also been characterized in an enhancer of the chicken
γE- and γF-crystallin genes (Králová et al., 2002), suggesting
that these factors act in concert to regulate additional targets.
Early and late phases in the establishment Hoxd4 neural
expression
Studies on another gene of paralogy group 4, Hoxb4, have
defined distinct early and late neural enhancers (Gould et al.,
1997, 1998). The early enhancer is dependent on a RARE
orthologous to that which we have defined in Hoxd4, while the
late enhancer harbors a pararegulatory element that binds
paralogy group 4 HOX proteins and is sufficient to set the r6/7
border. While Hoxd4 lacks this pararegulatory element, Hoxd4
expression in SeyNeu mice also follows early and latedynamics. Thus, at E8.5 and E8.75, Hoxd4 transcript levels
are depressed throughout the Hoxd4 domain of SeyNeu
homozygotes (Fig. 6), but are restored by E11 (data not
shown). Likewise, the altered hoxd4a anterior expression
border following pax6a and pax6b MO injection is rescued
later in development (data not shown). Thus, mechanisms
governing Hoxd4 expression at early and late times are
distinct, as for Hoxb4 (Gould et al., 1998), and consistent with
other studies on Hoxd4 (Maves and Kimmel, 2005). This
observation correlates well with our finding that PAX6 is only
associated with the Hoxd4 enhancer in posterior embryonic
tissue on E8, but not on E10. Thus, at both the molecular and
genetic levels, Pax6 distinguishes early from late Hoxd4
neural enhancer function. Our previous work showed that
hours before Hoxd4 transcripts are detectable in the E8 mouse
embryo, histones at the neural enhancer have acquired the
acetylation and methylation signatures of transcriptionally
active chromatin, and the histone acetyltransferase (HAT)
CREB binding protein (CBP) has been recruited (Rastegar et
al., 2004). Chromatin thus anticipates gene activation at the
Hoxd4 enhancer. The molecular and genetic evidence
presented here suggests that PAX6, along with retinoid
receptors, is responsible for these early changes, supported
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p300 (Hussain and Habener, 1999; Weston et al., 2003).
Evolutionary conservation of the intersection of AP and DV
patterning systems
A surprising implication of our studies is that PAX6, a protein
known for its key role in DV patterning of the CNS, also
contributes to the setting of theHoxd4 anterior expression border.
In fact, down-regulation of pax6a and pax6b generates wide-
spread AP patterning defects within rhombomeres (Figs. 7E–H),
suggesting a broad role for Pax6 in hindbrain morphogenesis
along the vertebrate rostro-caudal axis. RA also directs both AP
and DV patterning (Wilson and Maden, 2005), providing Hoxd4,
and perhaps Hox genes generally, with the means to integrate
positional cues from the same two classes of transcription factor
(retinoid receptors and PAX6) for precise spatio-temporal
activation across the AP and DVaxes of the neural tube.
Previous studies have demonstrated the integration of AP and
DV positional cues in the elaboration of neural-specific gene
expression patterns and neuronal cell type (Dasen et al., 2003;
Gaufo et al., 2004; Pattyn et al., 2003; Samad et al., 2004;
Wilson et al., 2004;Wilson andMaden, 2005). Evidence that AP
and DV patterning mechanisms are likely to be cross-referenced
at additional levels is given by the demonstration that HOX-
containing complexes influence the neural-specific expression
of Pax3 (Pruitt et al., 2004). The selective advantage to
reciprocal control by distinct axial patterning systems could
arise from increased precision in setting expression/compart-
ment borders in time and space. For example, DV signals could
restrict Hox expression to appropriate positions along this axis
(Krieger et al., 2004). Thus, many more instances of reciprocal
AP–DV regulatory interactions can be expected.
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